HIV in the world

UNAIDS_FactSheetUNAIDS_FactSheet (195 KB)

Global HIV statistics

  • 0 million [33.1 million–45.7 million] people globally were living with HIV in 2022.
  • 3 million [1 million–1.7 million] people became newly infected with HIV in 2022.
  • 630 000 [480 000–880 000] people died from AIDS-related illnesses in 2022.
  • 8 million people were accessing antiretroviral therapy in 2022.
  • 6 million [64.8 million–113.0 million] people have become infected with HIV since the start of the epidemic.
  • 4 million [32.9 million–51.3 million] people have died from AIDS-related illnesses since the start of the epidemic.

People living with HIV

  • In 2022, there were 39.0 million [33.1 million–45.7 million] people living with HIV.
    • 5 million [31.8 million–43.6 million] adults (15 years or older).
    • 5 million [1.2 million–2.1 million] children (0–14 years).
    • 53% of all people living with HIV were women and girls.
  • 86% [73– >98%] of all people living with HIV knew their HIV status in 2022.
  • About 5.5 million people did not know that they were living with HIV in 2022.

People living with HIV accessing antiretroviral therapy

  • At the end of December 2022, 29.8 million people were accessing antiretroviral therapy, up from 7.7 million in 2010.
  • In 2022, 76% [65–89%] of all people living with HIV were accessing treatment.
    • 77% [65–90%] of adults aged 15 years and older living with HIV had access to treatment, as did 57% [44–78%] of children aged 0–14 years.
    • 82% [69–95%] of women aged 15 years and older had access to treatment; however, just 72% [60–84%] of men aged 15 years and older had access.
  • 82% [64–98%] of pregnant women living with HIV had access to antiretroviral medicines to prevent transmission of HIV to their child in 2022.

New HIV infections

  • New HIV infections have been reduced by 59% since the peak in 1995.
    • In 2022, 1.3 million [1 million–1.7 million] people were newly infected with HIV, compared to 3.2 million [2.5 million–4.3 million] people in 1995.
    • Women and girls accounted for 46% of all new infections in 2022.
  • Since 2010, new HIV infections have declined by 38%, from 2.1 million [1.6 million–2.8 million] to 1.3 million [1 million–1.7 million] in 2022.
  • Since 2010, new HIV infections among children have declined by 58%, from 310 000 [210 000–490 000] in 2010 to 130 000 [90 000–210 000] in 2022.

AIDS-related deaths

  • AIDS-related deaths have been reduced by 69% since the peak in 2004 and by 51% since 2010.
  • In 2022, around 630 000 [480 000–880 000] people died from AIDS-related illnesses worldwide, compared to 2.0 million [1.5 million–2.8 million] people in 2004 and 1.3 million [970 000–1.8 million] people in 2010.
  • AIDS-related mortality has declined by 55% among women and girls and by 47% among men and boys since 2010.

Key Populations

  • Globally, median HIV prevalence among the adult population (ages 15-49) was 0.7%. However median prevalence was higher among key populations
    • 5% among sex workers
    • 7% among gay men and other men who have sex with men
    • 0% among people who inject drugs
    • 3% among transgender persons
    • 4% among people in prisons.

Women and girls

  • Globally 46% of all new HIV infections were among women and girls (all ages) in 2022.
  • In sub-Saharan Africa, women and girls (all ages) accounted for 63% of all new HIV infections.  In all other geographical regions, over 70% of new HIV infections in 2022 occurred among men and boys.
  • Every week, 4000 adolescent girls and young women aged 15–24 years became infected with HIV globally in 2022. 3100 of these infections occurred in sub-Saharan Africa.

Testing and treatment targets (95–95–95)

  • In 2022, 86% [73– >98%] of all people living with HIV knew their HIV status. Among people who knew their status, 89% [75– >98%] were accessing treatment. And among people accessing treatment, 93% [79– >98%] were virally suppressed.
  • Among children ages 0-14 years the 95-95-95 targets were 63% [49% - 86%], 91% [71% - >98%], 81% [63%->98%] Among women, the 95-95-95 targets were: 90% [76->98%], 91% [77->98%], and 93% [79->98%].
  • Among men, the 95-95-95 targets were: 83% [70-98%] of adult men living with HIV knew their HIV status, 86% [72->98%] were accessing treatment and 94% [79->98%] were virally suppressed.
  • Among all people living with HIV, 86% [73– >98%] knew their status, 76% [65–89%] were accessing treatment and 71% [60–83%] were virally suppressed in 2022.

Investments

  • At the end of 2022, US$ 20.8 billion (in constant 2019 United States dollars) was available for the AIDS response in low- and middle-income countries—around 60% was from domestic sources.
  • UNAIDS estimates that US$ 29 billion (in constant 2019 United States dollars) will be required for the AIDS response in low- and middle-income countries, including countries formerly considered to be upper-income countries, in 2025 to get on track to end AIDS as a public health threat.